Pfizer Currently Down Eight Consecutive Days, On Track for Longest Losing Streak Since June 2023 — Data Talk
Pfizer Inc. (PFE) is currently at $27.14, down $0.40 or 1.43%
--Would be lowest close since April 30, 2024, when it closed at $25.62
--Currently down eight consecutive days; down 8.17% over this period
--Longest losing streak since June 29, 2023, when it fell for eight straight trading days
--Worst eight day stretch since the eight days ending Dec. 15, 2023, when it fell 8.46%
--Down 5.32% month-to-date
--Down 5.75% year-to-date
--Down 55.7% from its all-time closing high of $61.25 on Dec. 16, 2021
--Down 32.26% from 52 weeks ago (June 16, 2023), when it closed at $40.06
--Down 32.26% from its 52-week closing high of $40.06 on June 16, 2023
--Up 7.42% from its 52-week closing low of $25.26 on April 25, 2024
--Traded as low as $27.13; lowest intraday level since May 2, 2024, when it hit $27.12
--Down 1.45% at today's intraday low
All data as of 11:25:45 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 17, 2024 11:43 ET (15:43 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks